These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12503941)

  • 1. Dispensing error leading to alendronate ingestion.
    Carrière B; Bailey B; Chabot G; Lebel D
    Ann Pharmacother; 2003 Jan; 37(1):87-9. PubMed ID: 12503941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroprotective effect of leukotriene receptor blocker montelukast in alendronat-induced lesions of the rat gastric mucosa.
    Sener G; Kapucu C; Cetinel S; Cikler E; Ayanoğlu-Dülger G
    Prostaglandins Leukot Essent Fatty Acids; 2005 Jan; 72(1):1-11. PubMed ID: 15589394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hallucination development with montelukast in a child with asthma: case presentation.
    Kocyigit A; Gulcan Oksuz B; Yarar F; Uzun F; Igde M; Islek I
    Iran J Allergy Asthma Immunol; 2013 Aug; 12(4):397-9. PubMed ID: 23996717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Esophagitis associated with use of alendronate in 5 postmenopausic patients].
    Luciani J; Pigatto V; Naves A; Fay M; Silvestre Begnis M; Piola JC; Prada DB; Pedrana R
    Acta Gastroenterol Latinoam; 2001 May; 31(2):59-63. PubMed ID: 11471319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alendronate-induced severe esophagitis. A rare and severe reversible side-effect illustrated by three case reports].
    Tóth E; Fork FT; Lindelöw K; Lindström E; Verbaan H; Veress B
    Lakartidningen; 1998 Aug; 95(35):3676-80. PubMed ID: 9748782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with a national medication error reporting program.
    Edgar TA; Lee DS; Cousins DD
    Am J Hosp Pharm; 1994 May; 51(10):1335-8. PubMed ID: 8085572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant medication dispensing among montelukast initiators.
    Zhou EH; Kaplan S; Mosholder A; Moeny D; Ding Y; Wu Y; Iyasu S; Hammad TA
    J Asthma; 2013 Nov; 50(9):990-5. PubMed ID: 23841530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pill esophagitis.
    Vãlean S; Petrescu M; Cãtinean A; Chira R; Mircea PA
    Rom J Gastroenterol; 2005 Jun; 14(2):159-63. PubMed ID: 15990936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alendronate-associated esophageal injury: pathologic and endoscopic features.
    Abraham SC; Cruz-Correa M; Lee LA; Yardley JH; Wu TT
    Mod Pathol; 1999 Dec; 12(12):1152-7. PubMed ID: 10619269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case-crossover study.
    Hauser T; Mahr A; Metzler C; Coste J; Sommerstein R; Gross WL; Guillevin L; Hellmich B
    Thorax; 2008 Aug; 63(8):677-82. PubMed ID: 18276721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of the incidence, nature and causes of dispensing errors in community pharmacies.
    Ashcroft DM; Quinlan P; Blenkinsopp A
    Pharmacoepidemiol Drug Saf; 2005 May; 14(5):327-32. PubMed ID: 15386722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharma-clinics. Medication of the month. Montelukast (Singulair)].
    Louis R
    Rev Med Liege; 2001 Jun; 56(6):460-2. PubMed ID: 11496728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
    Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
    Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alendronate-induced esophagitis: possible pathogenic role of hypersensitivity to alendronate.
    Naniwa T; Maeda T; Mizoshita T; Hayami Y; Watanabe M; Banno S; Ito R
    Intern Med; 2008; 47(23):2083-5. PubMed ID: 19043266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alendronate-induced esophagitis: case report of a recently recognized form of severe esophagitis with esophageal stricture--radiographic features.
    Ryan JM; Kelsey P; Ryan BM; Mueller PR
    Radiology; 1998 Feb; 206(2):389-91. PubMed ID: 9457190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montelukast, a leukotriene receptor antagonist, in vernal keratoconjunctivitis associated with asthma.
    Lambiase A; Bonini S; Rasi G; Coassin M; Bruscolini A; Bonini S
    Arch Ophthalmol; 2003 May; 121(5):615-20. PubMed ID: 12742837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology and type of medication errors reported to the National Poisons Information Centre of Ireland.
    Cassidy N; Duggan E; Williams DJ; Tracey JA
    Clin Toxicol (Phila); 2011 Jul; 49(6):485-91. PubMed ID: 21824059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
    Virchow JC; Bachert C
    Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
    Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
    Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.